Skip to content

Enterprise value at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$21.45B-5.6%
Artivion logo
ArtivionAORT
$1.96B+44.0%
AngioDynamics logo
AngioDynamicsANGO
$441.62M+30.5%
AIR
AirSculpt Technologies, Inc.AIRS
$231.02M+1.0%
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$1.48B
AtriCure logo
AtriCureATRC
$1.35B-13.1%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Calculated from Apyx Medical Corporation’s reported figures.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's enterprise value?
Apyx Medical Corporation (APYX) reported enterprise value of $162.67M in Q1 2026.
How has Apyx Medical Corporation's enterprise value changed year-over-year?
Apyx Medical Corporation's enterprise value increased by 172.6% year-over-year, from $59.68M to $162.67M.
What is the long-term trend for Apyx Medical Corporation's enterprise value?
Over 5 years (2020 to 2025), Apyx Medical Corporation's enterprise value has grown at a -6.0% compound annual growth rate (CAGR), from $205.97M to $151.22M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.